| Patient | Florence Nightingale |
|---|---|
| Date of birth | 1988-05-12 |
| Identifiers | MRN HR-NI004-SYN; SSN (made up) 000-04-9271 |
| Document date | 2026-03-02 |
| Author | Isobel Marchetti, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Suspected post-infectious ME/CFS in a 37-year-old nurse administrator who was treated for brucellosis abroad. Before we attribute her symptoms to ME/CFS, please assess for relapsed or focal brucellosis or another persisting infection. [S]
Urgency: Routine, within two weeks. [S]
Questions for the consultant:
Nearly three years ago, while leading nurses at an overseas field hospital, she had a severe febrile illness with sweats and aches; a Brucella agglutination titer there was reported positive and she completed six weeks of doxycycline and rifampin, with the fever resolving. Since then she has had debilitating fatigue worsened by activity, post-exertional malaise lasting days, unrefreshing sleep, and cognitive difficulty, worse after an intense period of work last year. She is housebound most days. Today she is afebrile; a ten-minute standing test shows a heart rate rise of 26/min without hypotension. No spinal or joint tenderness and no liver or spleen enlargement. The NICE exclusion tests, including ESR and CRP, were drawn today [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day | One to two tablets by mouth every 6 hours as needed; no more than 3 g a day | Oral route | 2025-11-03 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS | active | confirmed | G93.32 | S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed. |
| Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse | active | confirmed | Z86.19 | S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| May 1855 | Crimean fever at Balaclava: dangerously ill and near death, then a slow and painful recovery; she called it typhus | D (CLM-0003) |
| May 1855 | Retrospective interpretation of the Crimean fever as brucellosis, without laboratory confirmation (possible, not established) | R (CLM-0004) |
| August 1857 | Overwork and failing health during the army health commission, with rest at Malvern, a collapse with cardiac symptoms, then nausea, insomnia, and palpitations; took to her bed or couch on doctors' orders but kept working | D (CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-02 | Body height | 170 | cm | S |
| 2026-03-02 | Body weight | 55 | kg | S |
| 2026-03-02 | Body mass index (BMI) [Ratio] | 19 | kg/m2 | S |
| 2026-03-02 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-03-02 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-03-02 | Heart rate | 78 | /min | S |
| 2026-03-02 | Respiratory rate | 14 | /min | S |
| 2026-03-02 | Body temperature | 36.6 | Cel | S |
| 2026-03-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-02 | Hemoglobin [Mass/volume] in Blood | 12.9 | g/dL | 11.6-15 g/dL | Normal | S |
| 2026-03-02 | Leukocytes [#/volume] in Blood by Automated count | 5.8 | 10*3/uL | 3.4-10.8 10*3/uL | Normal | S |
| 2026-03-02 | Platelets [#/volume] in Blood by Automated count | 246 | 10*3/uL | 150-450 10*3/uL | Normal | S |
| 2026-03-02 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-02 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-03-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 110 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-02 | Glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-02 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.2 mg/dL | Normal | S |
| 2026-03-02 | Albumin [Mass/volume] in Serum or Plasma | 4.3 | g/dL | 3.5-5.2 g/dL | Normal | S |
| 2026-03-02 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 16 | U/L | 7-35 U/L | Normal | S |
| 2026-03-02 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 | U/L | 10-35 U/L | Normal | S |
| 2026-03-02 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 68 | U/L | 44-121 U/L | Normal | S |
| 2026-03-02 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-03-02 | Phosphate [Mass/volume] in Serum or Plasma | 3.6 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-03-02 | Erythrocyte [Sedimentation Rate] in Blood by Westergren method | 8 | mm/h | <=20 mm/h | Normal | S |
| 2026-03-02 | C reactive protein [Mass/volume] in Serum or Plasma | 1.2 | mg/L | <=5 mg/L | Normal | S |
| 2026-03-02 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-03-02 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.1 | % | <=5.6% | Normal | S |
| 2026-03-02 | Ferritin [Mass/volume] in Serum or Plasma | 48 | ng/mL | 30-150 ng/mL | Normal | S |
| 2026-03-02 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 1 | U/mL | <=3.9 U/mL | Normal | S |
| 2026-03-02 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 92 | U/L | 26-192 U/L | Normal | S |
| 2026-03-02 | Cortisol [Mass/volume] in Serum or Plasma | 14.2 | ug/dL | 6.2-19.4 ug/dL | Normal | S |
| 2026-03-02 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-03-02 | Folate [Mass/volume] in Serum or Plasma | 12.4 | ng/mL | >=5.9 ng/mL | Normal | S |
| 2026-03-02 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 17 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-03-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-03-02 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 2026-03-02 | PROMIS fatigue - version 1.0 Tscore | 71 | {score} | S | ||
| 2026-03-02 | PROMIS physical function - version 1.0 Tscore | 32 | {score} | S | ||
| 2026-03-02 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S |